Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01803854 · ClinicalTrials.gov registry record
Gulf War Era Cohort and Biorepository
A clinical trial of Gulf War Era Cohort, sponsored by VA Office of Research and Development.
- Active
- Registry status
- 1,275
- Enrollment target
- 1
- Study location
NCT01803854: Active study of Gulf War Era Cohort, sponsored by VA Office of Research and Development.
NCT01803854 is a study of Gulf War Era Cohort that is active but no longer recruiting, run by VA Office of Research and Development. The registered enrollment target is 1,275 participants. The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01803854, a study of Gulf War Era Cohort, is active but no longer recruiting, sponsored by VA Office of Research and Development.
- ACTIVE NOT RECRUITING
- Registry status
- 1,275 participants
- Enrollment target
- 1
- Study location
Study Summary
The Gulf War Era Cohort and Biorepository pilot project collected epidemiological, survey, clinical, and environmental exposure data from Veterans who served during the 1990-1991 Gulf War Era. Approved researchers will be able to use these data and the blood samples to do future research about the health of Gulf War Era Veterans. During the pilot, the recruitment response rate and processes were assessed. The results revealed several opportunities for improvement. For this reason, CSP 585 research activities transitioned to a qualitative phase to focus more on the Veteran voice. In this stage, research staff spoke with Gulf War Era Veterans through focus groups, interviews, and other activities such as events and meetings to learn more about Veterans' experiences and/or ideas on this and other Gulf War research projects. This phase provided new information that can help researchers create better recruitment processes for future projects involving Gulf War Era Veterans. For more information on CSP 585, please contact Asia Johnson at asia.johnson4@va.gov and Christina Williams at christina.williams4@va.gov
Primary Outcome
Use of VHA for health care in the past year
Conditions Studied
Study Locations (1)
North Carolina
- Durham VA Medical Center, Durham, NC - Durham
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 1,275 participants |
| Start Date | 2014-09-02 |
| Est. Completion | 2026-07-20 |
What the registry record for NCT01803854 still lists
NCT01803854 is an observational study that tracks outcomes without assigning an intervention. Its 1,275 participants enrollment target places it among the larger protocols in the corpus.
The record links to 1 condition, with Gulf War Era Cohort appearing as the primary indexed condition, and to 0 interventions.
NCT01803854 reports a single indexed study location in North Carolina.
Frequently Asked Questions
What is clinical trial NCT01803854 about?
NCT01803854 is a clinical study titled "Gulf War Era Cohort and Biorepository". The Gulf War Era Cohort and Biorepository pilot project collected epidemiological, survey, clinical, and environmental exposure data from Veterans who served during the 1990-1991 Gulf War Era. Approved researchers will be able to use these data and the blood samples to do future research about the h...
What is the current status of trial NCT01803854?
This trial is currently active not recruiting. The enrollment target is 1,275 participants. The study started on 2014-09-02. Estimated completion is 2026-07-20.
What conditions does trial NCT01803854 study?
This clinical trial studies the following conditions: Gulf War Era Cohort.
Who is sponsoring clinical trial NCT01803854?
This trial is sponsored by VA Office of Research and Development, which has 1,668 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT01803854 being conducted?
This trial has 1 study location across North Carolina. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT07225504 · 1,275 participants · Phase 3
A Study to Evaluate the Efficacy and Safety of Remibrutinib in Secondary Progressive Multiple Sclerosis
- NCT07001800 · 1,276 participants · Phase 2
Ataciguat for Slowing the Progression of Moderate Calcific Aortic Valve Stenosis: A Randomized, Placebo Controlled Study
- NCT03678025 · 1,273 participants · Phase 3
Standard Systemic Therapy With or Without Definitive Treatment in Treating Participants With Metastatic Prostate Cancer
- NCT03970447 · 1,280 participants · Phase 2
A Trial to Evaluate Multiple Regimens in Newly Diagnosed and Recurrent Glioblastoma
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI